Phleum Pratense and Dactylis Glomerata Allergen Extracts Standardization

NACompletedINTERVENTIONAL
Enrollment

31

Participants

Timeline

Start Date

December 9, 2024

Primary Completion Date

January 13, 2025

Study Completion Date

January 16, 2025

Conditions
Allergy PollenAllergic ReactionAllergic Skin Reaction
Interventions
OTHER

Allergenic extracts

In each subject, a drop of each of the 3 concentrations of the allergenic extract, in addition to the positive control (histamine) and the negative control, will be applied. The application will be duplicated on the subject's anterior forearm, with a distance of approximately 4 cm between each application to avoid overlapping reactions and false-positives results.

Trial Locations (1)

28006

Clínica de Asma y Alergia Dres. Ojeda, Madrid

Sponsors

Lead Sponsor

All Listed Sponsors
lead

Inmunotek S.L.

INDUSTRY

NCT06957496 - Phleum Pratense and Dactylis Glomerata Allergen Extracts Standardization | Biotech Hunter | Biotech Hunter